Aparna Nathan, PhD
Aparna is a freelance science writer pursuing a PhD in bioinformatics and genomics at Harvard University. She uses her multidisciplinary training to find both the cutting-edge science and the human stories in everything from genetic testing to space expeditions. She was recently a 2021 AAAS Mass Media Fellow at the Philadelphia Inquirer. Her writing has also appeared in Popular Science, PBS NOVA, and The Open Notebook.
Articles by Aparna Nathan, PhD
| 9 min read
Chemoproteomic tools are yielding early drug candidates for previously undruggable proteins.
| 8 min read
Virus-inspired delivery methods enable gene editing of dysregulated microbes.
| 4 min read
New data show that NK cell engagers may provide a robust alternative to T cell therapies.
| 9 min read
With new tools, researchers hope to improve diagnosis of platelet dysfunction by measuring their forces.
| 9 min read
Drug repurposing trials for ichthyosis reveal complexity in the long-untreated disease.
| 9 min read
A saliva-based test could make it easier to diagnose concussions.
| 10 min read
Customizable hydrogels could make taking diabetes and cancer medications as well as other biologics easier for patients.
| 10 min read
A modular CAR T cell could make cancer therapy safer and more effective.
| 8 min read
A new approach to cell engineering could make off-the-shelf CAR T cell therapies a reality.
| 10+ min read
Slowing female reproductive aging could be the key to improving women’s health.
| 7 min read
A new antibody drug should improve treatment of a rare autoimmune encephalitis.
| 7 min read
A one-time gene therapy aims to stop Huntington's disease at its source. But first, it has to survive clinical trials.
| 7 min read
As an alternative to reconstructive surgery, a degradable implant may offer a new way for the body to reconstruct a breast after mastectomy.
| 8 min read
Dental stem cells’ regenerative powers can help heal more than just teeth.
| 7 min read
Stress affects mental health in obvious ways, but it can also exacerbate cardiac disease and interfere with cancer treatment.
Page 1 of 2 - 29 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Reliable fluid biomarkers strategies for clinical neuroscience research
Explore how validated fluid biomarker assays advance clinical research for neurological diseases.
Understanding drug impurities: types, sources, and analytical strategies
Unseen and often unexpected, drug impurities can slip in at every drug development stage, making their detection and control essential.
Discovering cutting-edge nitrosamine analysis in pharmaceuticals
New tools help researchers detect and manage harmful nitrosamine impurities in drugs such as monoclonal antibodies.
